According to World Health Organisation (2017), Cardiovascular Disease (CVD) is currently the first leading cause of death worldwide. There has been an increase of 14.5% of deaths which is equivalent to 17.9 million, attributed to cardiovascular diseases (CVDs) globally from 2006 to 2016. That is 3 in every 10 deaths and is expected to grow to over 23.6 million by 2030.
The major risk factors for cardiovascular disease are smoking, high blood pressure and high blood cholesterol. These risk factors can be prevented by addressing common lifestyle habits such as the smoking cessation, reduction of salt in the diet, increased consumption of fruits and vegetables, regular physical activity and limiting alcohol intake.
(American Institute for Cancer Research)
Over the years, the global food system has evolved along with the public food behaviours. The frequency of snacking, eating out, ordering take-outs and fast food consumption have escalated in low and middle income countries, resulting in a dietary shift to a higher consumption of refined carbohydrates, vegetable oils, meat, processed foods and sweetened beverages. These dietary patterns contribute extra calories, sugar, salt and fat to the diet and consequently a higher risk of heart diseases.
BARLEANS
Truelifesciences has provided an easy way to counter these issues with our clinically formulated products. Barleans is a pharmaceutical grade high strength fish oil with ethyl ester form of omega 3 acid that is clinically proven to prevent heart disease. Barleans can help in lowering your triglyceride and cholesterol level, reducing blood pressure and promoting a better heart health.
Click here to find out more about Barleans
Quinol CoQH-CF (Ubiquinol Reduced Coenzyme Q10)
Coenzyme Q10 is a fat-soluble nutrient produced naturally in our bodies essential in the process of producing cellular energy that also helps in lowering blood pressure and improving heart health. Unfortunately, the functions of our body decline as we age and so is the CoQ10 level in the body. A compromised CoQ10 status usually brings forth complications such as physical fatigue, muscle weakness and cognitive impairment. It is also closely related to chronic illnesses like cardiovascular diseases, diabetes mellitus, muscular dystrophy and others.
Quinol COQH-CF is a ubiquinol reduced coenzyme Q10 patented with crystal free tri-lipid technology, leading to 8x better absorption than other quinol supplements while it is also clinically proven to improve heart health. It contains D-Limonene, Alpha-lipoic acid, Capric acid and Caprylic acid which provides a viable and stable form of ubiquinol, making it highly bioavailable to the body.